These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32197712)

  • 1. Therapeutic applications of thyroid hormone analogues.
    Visser WE
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):170-172. PubMed ID: 32197712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.
    Groeneweg S; Peeters RP; Visser TJ; Visser WE
    Mol Cell Endocrinol; 2017 Dec; 458():82-90. PubMed ID: 28235578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8.
    Bárez-López S; Grijota-Martínez C; Liao XH; Refetoff S; Guadaño-Ferraz A
    PLoS One; 2019; 14(12):e0226017. PubMed ID: 31809508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to thyroid hormones].
    Jiskra J; Límanová Z
    Cas Lek Cesk; 2014; 153(3):137-41. PubMed ID: 24968291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of Thyroid hormones in MCT8 deficiency.
    Grijota-Martínez C; Bárez-López S; Ausó E; Refetoff S; Frey WH; Guadaño-Ferraz A
    PLoS One; 2020; 15(7):e0236113. PubMed ID: 32687511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impaired sensitivity to thyroid hormone].
    Kvistad SA; Methlie P; Løvås K; Sagen JV
    Tidsskr Nor Laegeforen; 2016 Apr; 136(7):618-22. PubMed ID: 27094663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance.
    Carbone A; Verrienti A; Cito DS; Sponziello M; Pecce V; Bruno R
    Endocrine; 2024 Aug; 85(2):598-600. PubMed ID: 38558372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular High Doses of 3,3',5-Triiodothyroacetic Acid at Juvenile Stages Improve Peripheral Hyperthyroidism and Mediate Thyromimetic Effects in Limited Brain Regions in a Mouse Model of Monocarboxylate Transporter 8 Deficiency.
    Grijota-Martínez C; Montero-Pedrazuela A; Hidalgo-Álvarez J; Bárez-López S; Guadaño-Ferraz A
    Thyroid; 2023 Apr; 33(4):501-510. PubMed ID: 36565029
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid hormone transporter defects.
    Grüters A
    Endocr Dev; 2007; 10():118-126. PubMed ID: 17684393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid Hormone Transporters.
    Groeneweg S; van Geest FS; Peeters RP; Heuer H; Visser WE
    Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31754699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Hormone Analogues: An Update.
    Zucchi R
    Thyroid; 2020 Aug; 30(8):1099-1105. PubMed ID: 32098589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with TRIAC in pediatric patients with MCT8.
    Gazek N; Feller AL; Vaiani E; Di Palma I; Savransky A; Ramírez P; Marino R; Pérez Garrido N; Lazzati JM; Herzovich V; Dujovne N
    Arch Argent Pediatr; 2023 Dec; 121(6):e202202968. PubMed ID: 36883873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.
    Cheng SY
    Trends Endocrinol Metab; 2005; 16(4):176-82. PubMed ID: 15860414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
    Guran T; Turan S; Bircan R; Bereket A
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromes of Resistance to Thyroid Hormone Action.
    Persani L; Campi I
    Exp Suppl; 2019; 111():55-84. PubMed ID: 31588528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific effects of mutations in the thyroid hormone transporter MCT8.
    Kersseboom S; Visser TJ
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):1-5. PubMed ID: 21468514
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid hormone transport in and out of cells.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Trends Endocrinol Metab; 2008 Mar; 19(2):50-6. PubMed ID: 18291666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac complications of thyroid hormone resistance syndromes.
    Illouz F; Briet C; Mirebeau-Prunier D; Bouhours-Nouet N; Coutant R; Sibilia P; Rodien P
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):167-169. PubMed ID: 32513415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels.
    Silvestri E; Lombardi A; de Lange P; Schiavo L; Lanni A; Goglia F; Visser TJ; Moreno M
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1160-8. PubMed ID: 18430970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.